Pharmaniaga Bhd (7081) - Total Liabilities

Latest as of March 2026: RM1.87 Billion MYR ≈ $468.97 Million USD

Based on the latest financial reports, Pharmaniaga Bhd (7081) has total liabilities worth RM1.87 Billion MYR (≈ $468.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. For the complete balance sheet picture, see 7081 total assets.

Pharmaniaga Bhd - Total Liabilities Trend (2012–2025)

This chart illustrates how Pharmaniaga Bhd's total liabilities have evolved over time, based on quarterly financial data. See Pharmaniaga Bhd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Pharmaniaga Bhd Competitors by Total Liabilities

The table below lists competitors of Pharmaniaga Bhd ranked by their total liabilities.

Company	Country	Total Liabilities
Enseval Putra Megatrading Tbk JK:EPMT	Indonesia	Rp4.53 Trillion
The Anup Engineering Limited NSE:ANUP	India	Rs3.61 Billion
Nanjing Aolian Ae&Ea Co Ltd SHE:300585	China	CN¥222.08 Million
First Bancorp Inc NASDAQ:FNLC	USA	$2.92 Billion
Enanta Pharmaceuticals Inc NASDAQ:ENTA	USA	$195.80 Million
GDI Integrated TO:GDI	Canada	CA$762.00 Million
K & S Corporation Ltd AU:KSC	Australia	AU$324.14 Million
Lux Industries Limited NSE:LUXIND	India	Rs12.03 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Pharmaniaga Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. Check Pharmaniaga Bhd (7081) asset resilience to evaluate the company's liquid asset resilience ratio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmaniaga Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmaniaga Bhd (2012–2025)

The table below shows the annual total liabilities of Pharmaniaga Bhd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	RM1.79 Billion ≈ $448.83 Million	-16.40%
2024-12-31	RM2.14 Billion ≈ $536.84 Million	-2.32%
2023-12-31	RM2.19 Billion ≈ $549.57 Million	-0.30%
2022-12-31	RM2.20 Billion ≈ $551.24 Million	+22.84%
2021-12-31	RM1.79 Billion ≈ $448.76 Million	+43.84%
2020-12-31	RM1.24 Billion ≈ $311.98 Million	-0.94%
2019-12-31	RM1.25 Billion ≈ $314.95 Million	-10.29%
2018-12-31	RM1.40 Billion ≈ $351.09 Million	+29.52%
2017-12-31	RM1.08 Billion ≈ $271.08 Million	-6.31%
2016-12-31	RM1.15 Billion ≈ $289.35 Million	+23.13%
2015-12-31	RM936.00 Million ≈ $235.00 Million	+35.46%
2014-12-31	RM691.00 Million ≈ $173.49 Million	+13.65%
2013-12-31	RM608.00 Million ≈ $152.65 Million	-17.28%
2012-12-31	RM735.00 Million ≈ $184.53 Million	--

About Pharmaniaga Bhd

KLSE:7081 Malaysia Medical Distribution

Market Cap

$391.81 Million

RM1.56 Billion MYR

Market Cap Rank

#13624 Global

#148 in Malaysia

Share Price

RM1.19

Change (1 day)

+0.00%

52-Week Range

RM0.17 - RM1.38

All Time High

RM1.38